I don’t find them tiresome. Transparency isn’t a bad thing. And yes, there won’t be any big news today which I wouldn’t expect. Regularly scheduled updates for shareholders in an OTC stock is a good idea because many are retail investors who get jittery to the point many cant handle the ebbs and flows of a small biotech company going for their first drug approval. It’s a maze going for that approval as many investors are finding out. If it’s peoples first ride with Biotech, they will bail many times because the process is longer than they want it to be. So it’s their way of keeping people on the boat.